Status:
UNKNOWN
Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
COVID-19
ECMO
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
assess the safety and effectiveness of using low-flow extracorporeal membrane oxygenation(CO2 removal) driving by CVVH machine in the severe NCP patients
Eligibility Criteria
Inclusion
- 1\. NCP with severe acute respiratory distress syndrome with ratio of partial pressure of arterial oxygen over fraction of inspired oxygen (PaO2:FiO2)\<150 and PEEP \>10cmH2O
- 2\. Driving pressure\> 20cmH2O
- 3\. RR\>30bpm
- PaCO2\>55cmH2O and/or PH\>7.3
Exclusion
- 1\. poor venous vascular condition and unavaible for central venous catheter placement
Key Trial Info
Start Date :
February 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04340414
Start Date
February 20 2020
End Date
October 15 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yun Long
Beijing, Beijing Municipality, China, 100730